KCNS1 (Potassium Voltage-Gated Channel Subfamily S Member 1) encodes a voltage-gated potassium channel subunit that plays important roles in neuronal excitability, pain signaling, and synaptic transmission. The protein forms part of delayed rectifier potassium channels that regulate action potential repolarization in neurons. [1]
| Property | Value | [2]
|----------|-------| [3]
| Gene Symbol | KCNS1 | [4]
| Gene Name | Potassium Voltage-Gated Channel Subfamily S Member 1 |
| Aliases | KV9.1, K+ voltage-gated channel protein S1 |
| Chromosomal Location | 2p24.2 |
| NCBI Gene ID | 3784 |
| OMIM | 603958 |
| UniProt | Q9BQD1 |
| Ensembl | ENSG00000124134 |
KCNS1 encodes the Kv9.1 subunit, a voltage-gated potassium (Kv) channel protein. Unlike typical Kv channels, KCNS1 functions as a modulatory subunit that does not form functional homomeric channels but instead assembles with other Kv channel subunits to modify their properties [1].
The KCNS1 protein contains several key domains:
When co-assembled with other Kv subunits (particularly Kv2.1), KCNS1 modifies channel properties:
KCNS1 demonstrates region-specific expression in the nervous system:
KCNS1-containing channels regulate neuronal firing properties:
KCNS1 plays a critical role in pain processing:
KCNS1 variants have been associated with epilepsy susceptibility:
KCNS1 dysfunction is linked to chronic pain conditions:
KCNS1 represents a potential therapeutic target:
Kv9.1 (KCNS1-containing channels) are under investigation for pain treatment:
Modulating KCNS1 activity may have antiepileptic potential:
KCNS1 encodes a modulatory voltage-gated potassium channel subunit with important roles in neuronal excitability and pain signaling. While not a primary cause of neurodegenerative diseases, understanding KCNS1 function provides insights into neuronal signaling mechanisms relevant to neurological disorders.
Tsantoulas et al. Brain (2017). 2017. ↩︎
Rashid et al. Journal of Neurophysiology (2013). 2013. ↩︎
Chandy et al. Nature Reviews Drug Discovery (2021). 2021. ↩︎